Literature DB >> 7587233

T-lymphocyte subsets in acute illness.

C Feeney1, S Bryzman, L Kong, H Brazil, R Deutsch, L C Fritz.   

Abstract

OBJECTIVES: To determine the range of T-lymphocyte subsets (CD4, CD8, and CD4/CD8 ratios) in acutely ill, hospitalized patients and to determine whether these concentrations correlate with illness severity, survival rate, or immunodepression.
DESIGN: Cross-sectional study, comparing Acute Physiology and Chronic Health Evaluation II (APACHE II) scores and the calculated, disease-specific, predicted mortality rate with T-lymphocyte subsets.
SETTING: Urban county hospital intensive care unit (ICU), serving as the designated trauma center. PATIENTS: One hundred two consecutively admitted ICU patients (72 medical and 30 surgical).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patient clinical data, APACHE II scores, and their associated predicted mortality rate were recorded. Blinded human immunodeficiency virus (HIV) and lymphocyte testing was performed on samples from all patients on ICU admission. Despite only three (2.9%) of 102 patients testing positive for HIV antibodies, 41% (42/102) of patients had CD4 concentrations of < 400 cells/microL, and 29% (29/102) had CD4 concentrations of < 300 cells/microL. Mean CD8 concentrations were even lower, compared with normal laboratory values, resulting in a slight increase in CD4/CD8 ratios, although 16% (16/102) of patients had a CD4/CD8 ratio of < 1. CD4 counts were linearly related to total lymphocyte concentrations (Pearson correlation coefficient = 0.948), but no relationship was found between total lymphocyte or lymphocyte subset counts and APACHE II score, predicted mortality rate, or survival rate.
CONCLUSIONS: Acute illness alone, in the absence of HIV infection, can be associated with profound decreases of T-lymphocyte populations. This problem is unpredictable and does not correlate with severity of illness, predicted mortality rate, or actual mortality rate. No conclusions regarding HIV serostatus or survival can be made based on single measurements of T-cell concentrations in acutely ill hospitalized patients.

Entities:  

Mesh:

Year:  1995        PMID: 7587233     DOI: 10.1097/00003246-199510000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?

Authors:  Howard B Gale; Steven R Gitterman; Heather J Hoffman; Fred M Gordin; Debra A Benator; Ann M Labriola; Virginia L Kan
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

3.  Enhanced in vivo protein synthesis in circulating immune cells of ICU patients.

Authors:  Anna Januszkiewicz; Maria Klaude; Karin Loré; Jan Andersson; Olle Ringdén; Olav Rooyackers; Jan Wernerman
Journal:  J Clin Immunol       Date:  2007-07-06       Impact factor: 8.317

4.  Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A.

Authors:  Zahid Hussain; Syed A Husain; Fahad N Almajhdi; Premashis Kar
Journal:  Virol J       Date:  2011-05-23       Impact factor: 4.099

5.  Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Authors:  Jennifer B Rosen; Joel G Breman; Charles R Manclark; Bruce D Meade; William E Collins; Hans O Lobel; Pierre Saliou; Jacquelin M Roberts; Pierre Campaoré; Mark A Miller
Journal:  Malar J       Date:  2005-11-06       Impact factor: 2.979

6.  Association between CD4 T cell counts and the immune status among adult critically ill HIV-negative patients in intensive care units in Uganda.

Authors:  Arthur Kavuma Mwanje; Joseph Ejoku; Lameck Ssemogerere; Clare Lubulwa; Christine Namata; Arthur Kwizera; Agnes Wabule; Erasmus Okello; Samuel Kizito; Aggrey Lubikire; Cornelius Sendagire; Irene Andia Biraro
Journal:  AAS Open Res       Date:  2019-01-08

7.  False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes.

Authors:  Leslie Shanks; Derryck Klarkowski; Daniel P O'Brien
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

Review 8.  Clinical review: immunodepression in the surgical patient and increased susceptibility to infection.

Authors:  Martin K Angele; Eugen Faist
Journal:  Crit Care       Date:  2002-05-24       Impact factor: 9.097

9.  Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mcl-1 proteins.

Authors:  Arwed Hostmann; Kerstin Jasse; Gundula Schulze-Tanzil; Yohan Robinson; Andreas Oberholzer; Wolfgang Ertel; Sven K Tschoeke
Journal:  Crit Care       Date:  2008-01-22       Impact factor: 9.097

10.  The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.

Authors:  Jamie Inshaw; Clifford Leen; Martin Fisher; Richard Gilson; David Hawkins; Simon Collins; Julie Fox; Ken McLean; Sarah Fidler; Andrew Phillips; Sam Lattimore; Abdel Babiker; Kholoud Porter
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.